Speaker illustration

Doctor Julian Gillmore

Royal Free London NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

Heart Failure Association

Julian Gillmore gained his medical degree at University of London and was appointed Professor of Medicine at University College London in 2017. He trained in nephrology and undertook MD and PhD degrees in the field of amyloidosis. His research interests include pathogenesis, diagnosis and treatment of amyloidosis. He was appointed Centre Head at UCL’s Centre for Amyloidosis & Acute Phase Proteins in 2019 and is clinical lead for ATTR amyloidosis at the UK National Amyloidosis Centre. He has published more than 250 peer-reviewed articles, has supervised a number of students through their post-doctoral research degrees, and has received extensive grant funding.

The advancing management of transthyretin amyloidosis: a practical guide

Event: ESC Congress 2023

Topic: Cardiac Amyloidosis

Session type: Satellite Symposium


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb